{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:13Z","timestamp":1789706233974,"version":"4.0.1"},"reference-count":378,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbcan.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T19:47:33Z","timestamp":1488224853000},"page":"69-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Biological determinants of radioresistance and their remediation in pancreatic cancer"],"prefix":"10.1016","volume":"1868","author":[{"given":"Parthasarathy","family":"Seshacharyulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Baine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J","family":"Souchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Menning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2017.02.003_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0015","series-title":"Surveillance Epidemiology and end Results Cancer Statistics Review 1975\u20132006","author":"National Cancer Institute","year":"2011"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0020","first-page":"132","article-title":"The determinant factors of recurrence following resection for ductal pancreatic cancer","volume":"8","author":"Barugola","year":"2007","journal-title":"JOP"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0025","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1245\/s10434-009-0670-7","article-title":"Resectable pancreatic cancer: who really benefits from resection?","volume":"16","author":"Barugola","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2017.02.003_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/1319-3767.93815","article-title":"Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy","volume":"18","author":"Fischer","year":"2012","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0035","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.surg.2012.05.015","article-title":"R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use","volume":"152","author":"Rau","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4297\/najms.2011.31","article-title":"Pancreatic cancer: chemotherapy and radiotherapy","volume":"3","author":"Andren-Sandberg","year":"2011","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0360-3016(01)02740-7","article-title":"Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?","volume":"52","author":"Crane","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0050","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2005.03.6780","article-title":"Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer","volume":"24","author":"Crane","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.1998.16.1.317","article-title":"Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern cooperative oncology group study","volume":"16","author":"Hoffman","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archsurg.1993.01420170093014","article-title":"Neoadjuvant therapy for unresectable pancreatic adenocarcinoma","volume":"128","author":"Jessup","year":"1993","journal-title":"Arch. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00268-004-7338-z","article-title":"Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer","volume":"28","author":"Wilkowski","year":"2004","journal-title":"World J. Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2017.02.003_bb0070","first-page":"20","article-title":"The role of radiation therapy in pancreas cancer","volume":"3","author":"Hazard","year":"2009","journal-title":"Gastrointest. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.11.6.303","article-title":"On the mechanism of X-ray scattering","volume":"11","author":"Compton","year":"1925","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0080","series-title":"Radiobiology for the Radiologist","author":"Hall","year":"2006"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0085","first-page":"1","article-title":"Sensing and signaling DNA damage: roles of Rad17 and Rad9 complexes in the cellular response to DNA damage","volume":"97","author":"Zou","year":"2001","journal-title":"Harvey Lect."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0955-0674(00)00201-5","article-title":"DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?","volume":"13","author":"Durocher","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0955-0674(02)00312-5","article-title":"A unified view of the DNA-damage checkpoint","volume":"14","author":"Melo","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0100","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1158\/1078-0432.CCR-07-1610","article-title":"The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage","volume":"13","author":"Chen","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0105","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1038\/sj.onc.1204767","article-title":"DNA double strand break repair and chromosomal translocation: lessons from animal models","volume":"20","author":"Ferguson","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0110","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.cdd.4400874","article-title":"ATM, a central controller of cellular responses to DNA damage","volume":"8","author":"Khanna","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints in perspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.genet.36.060402.113540","article-title":"Toward maintaining the genome: DNA damage and replication checkpoints","volume":"36","author":"Nyberg","year":"2002","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/156800907780809769","article-title":"ATM-NF-kappaB connection as a target for tumor radiosensitization","volume":"7","author":"Ahmed","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1105\/tpc.150110","article-title":"ATM to the rescue: repairing DNA damage","volume":"15","author":"Eckardt","year":"2003","journal-title":"Plant Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006318","article-title":"A multifaceted role for ATM in genome maintenance","volume":"5","author":"Pandita","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0155","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/7.10.1555","article-title":"ATM: from gene to function","volume":"7","author":"Rotman","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0160","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.4161\/cc.9.18.13253","article-title":"Differential localization of ATM is correlated with activation of distinct downstream signaling pathways","volume":"9","author":"Alexander","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0165","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1074\/jbc.M611605200","article-title":"Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2009.04.088","article-title":"ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions","volume":"75","author":"Xue","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0360-3016(88)90125-3","article-title":"Faster repair of DNA double-strand breaks in radioresistant human tumor cells","volume":"15","author":"Schwartz","year":"1988","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2307\/3577394","article-title":"Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity","volume":"116","author":"Kelland","year":"1988","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90229-N","article-title":"The use of asymmetric-field inversion gel electrophoresis to predict tumor cell radiosensitivity","volume":"24","author":"Giaccia","year":"1992","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrm805","article-title":"The Mre11 complex: at the crossroads of dna repair and checkpoint signalling","volume":"3","author":"D'Amours","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0195","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/302391","article-title":"The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response","volume":"64","author":"Petrini","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/85798","article-title":"DNA double-strand breaks: signaling, repair and the cancer connection","volume":"27","author":"Khanna","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1074740","article-title":"Interfaces between the detection, signaling, and repair of DNA damage","volume":"297","author":"Rouse","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90360-7","article-title":"Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation","volume":"80","author":"Blunt","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0215","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1073\/pnas.93.19.10285","article-title":"Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse","volume":"93","author":"Blunt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/bies.950171108","article-title":"Menage a trois: double strand break repair, V(D)J recombination and DNA-PK","volume":"17","author":"Jeggo","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0225","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/carcin\/23.5.687","article-title":"Sensing and repairing DNA double-strand breaks","volume":"23","author":"Jackson","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0230","first-page":"270","article-title":"Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2","volume":"61","author":"Wang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0235","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.onc.1204350","article-title":"Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group","volume":"20","author":"Wang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0240","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1073\/pnas.151253498","article-title":"Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0245","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1038\/sj.onc.1206682","article-title":"DNA damage checkpoint control in cells exposed to ionizing radiation","volume":"22","author":"Iliakis","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0250","article-title":"Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35043058","article-title":"The many substrates and functions of ATM","volume":"1","author":"Kastan","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"Moynahan","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0265","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.genet.31.1.635","article-title":"Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart","volume":"31","author":"Shiloh","year":"1997","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(00)81175-7","article-title":"The hMre11\/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response","volume":"93","author":"Carney","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.molcel.2015.12.010","article-title":"FBXW7 facilitates nonhomologous end-joining via K63-linked polyubiquitylation of XRCC4","volume":"61","author":"Zhang","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0280","first-page":"467","article-title":"Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells","volume":"11","author":"Satyamoorthy","year":"2000","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0285","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0295","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0300","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/MCB.4.9.1689","article-title":"UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells","volume":"4","author":"Maltzman","year":"1984","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0305","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/sj.onc.1201104","article-title":"The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate","volume":"14","author":"Chernov","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0310","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/MCB.17.6.3074","article-title":"p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle","volume":"17","author":"Haapajarvi","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0315","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","article-title":"Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage","volume":"96","author":"Chehab","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0320","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1126\/science.287.5459.1824","article-title":"DNA damage-induced activation of p53 by the checkpoint kinase Chk2","volume":"287","author":"Hirao","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0325","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","article-title":"A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia","volume":"71","author":"Kastan","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0330","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","article-title":"The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites","volume":"14","author":"Shieh","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0335","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","article-title":"Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53","volume":"14","author":"Chehab","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0345","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/emboj\/18.7.1805","article-title":"Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2","volume":"18","author":"Unger","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0350","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0355","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/07357909909011718","article-title":"The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation","volume":"17","author":"Rosen","year":"1999","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0365","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/377646a0","article-title":"Induction of the growth inhibitor IGF-binding protein 3 by p53","volume":"377","author":"Buckbinder","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0370","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0380","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.7973727","article-title":"Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen","volume":"266","author":"Smith","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0385","first-page":"2755","article-title":"The p53-dependent gamma-ray response of GADD45","volume":"54","author":"Zhan","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0390","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.89.16.7491","article-title":"Wild-type p53 is a cell cycle checkpoint determinant following irradiation","volume":"89","author":"Kuerbitz","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0395","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0400","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0405","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.2683079","article-title":"Checkpoints: controls that ensure the order of cell cycle events","volume":"246","author":"Hartwell","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/CritRevOncog.v9.i1.60","article-title":"Mechanisms of p53-mediated apoptosis","volume":"9","author":"Ding","year":"1998","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gde.2003.12.003","article-title":"DNA damage tumor suppressor genes and genomic instability","volume":"14","author":"Motoyama","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0420","first-page":"M43","article-title":"p21(WAF1\/Cip1): more than a break to the cell cycle?","volume":"1471","author":"Dotto","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0425","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","article-title":"Inhibitors of mammalian G1 cyclin-dependent kinases","volume":"9","author":"Sherr","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0430","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4781(01)00204-4","article-title":"Checking out the G(2)\/M transition","volume":"1519","author":"Smits","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0440","first-page":"1412","article-title":"Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2","volume":"54","author":"Kharbanda","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0445","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/emboj\/16.3.545","article-title":"Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation","volume":"16","author":"O'Connell","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0450","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/gad.11.4.504","article-title":"Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast","volume":"11","author":"Rhind","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0455","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/44188","article-title":"14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage","volume":"401","author":"Chan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","article-title":"14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression","volume":"1","author":"Hermeking","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0465","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.277.5331.1501","article-title":"Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216","volume":"277","author":"Peng","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0470","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/carcin\/bgh159","article-title":"Enhanced expression of 14-3-3 sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis","volume":"25","author":"Guweidhi","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0475","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1158\/1078-0432.CCR-08-1366","article-title":"14-3-3sigma modulates pancreatic cancer cell survival and invasiveness","volume":"14","author":"Neupane","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2017.02.003_bb0480","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr3164","article-title":"RAC1 GTPase plays an important role in gamma-irradiation induced G2\/M checkpoint activation","volume":"14","author":"Yan","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0485","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.18632\/oncotarget.2500","article-title":"Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to gamma-irradiation","volume":"5","author":"Yan","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0490","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00018-008-8552-x","article-title":"Rac1 GTPase: a \u201cRac\u201d of all trades","volume":"66","author":"Bosco","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0495","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1073\/pnas.0307512101","article-title":"Rational design and characterization of a Rac GTPase-specific small molecule inhibitor","volume":"101","author":"Gao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0500","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/35077207","article-title":"Cancer genetics","volume":"411","author":"Ponder","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0505","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1389201043376698","article-title":"Role of genomics-based strategies in overcoming chemotherapeutic resistance","volume":"5","author":"Kumar","year":"2004","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0510","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2307\/3579456","article-title":"Radiation inactivation of human prostate cancer cells: the role of apoptosis","volume":"146","author":"Algan","year":"1996","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrc1560","article-title":"The role of apoptosis in cancer development and treatment response","volume":"5","author":"Brown","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0520","first-page":"1","article-title":"Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B","volume":"1","author":"Dai","year":"2009","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0525","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1535-7163.985.3.8","article-title":"Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells","volume":"3","author":"Munshi","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0530","first-page":"4901","article-title":"Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0535","first-page":"2573","article-title":"Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice","volume":"6","author":"Huang","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0540","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2005.09.036","article-title":"PIDD mediates NF-kappaB activation in response to DNA damage","volume":"123","author":"Janssens","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0545","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1158\/0008-5472.CAN-05-1330","article-title":"Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer","volume":"65","author":"Banerjee","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0550","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-kappaB in preventing TNF-alpha-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0555","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0560","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/sj.onc.1204365","article-title":"Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells","volume":"20","author":"Chinni","year":"2001","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.bbcan.2017.02.003_bb0565","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1158\/1078-0432.CCR-08-0188","article-title":"Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis","volume":"14","author":"Dai","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0570","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","article-title":"To be, or not to be: NF-kappaB is the answer\u2014role of Rel\/NF-kappaB in the regulation of apoptosis","volume":"22","author":"Kucharczak","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0575","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2741\/1523","article-title":"Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells","volume":"10","author":"Li","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0580","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-04-4604","article-title":"Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells","volume":"65","author":"Li","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0585","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2006.07.023","article-title":"Can NF-kappaB be a target for novel and efficient anti-cancer agents?","volume":"72","author":"Olivier","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0590","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2741\/2900","article-title":"NF-kappaB: a potential target for cancer chemoprevention and therapy","volume":"13","author":"Sarkar","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0595","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","article-title":"NF-kappaB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis","volume":"19","author":"Wang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0600","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/7410","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0610","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/40901","article-title":"X-linked IAP is a direct inhibitor of cell-death proteases","volume":"388","author":"Deveraux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0615","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1023\/A:1020502800208","article-title":"Endogenous inhibitors of caspases","volume":"19","author":"Deveraux","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0620","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10495-007-0087-3","article-title":"The inhibitors of apoptosis (IAPs) as cancer targets","volume":"12","author":"Hunter","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0625","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","article-title":"Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice","volume":"64","author":"Schimmer","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0630","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molcel.2008.03.008","article-title":"IAPs: what's in a name?","volume":"30","author":"Srinivasula","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0635","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-7-64","article-title":"Apoptotic pathways in pancreatic ductal adenocarcinoma","volume":"7","author":"Hamacher","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0640","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jor.20377","article-title":"Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells","volume":"25","author":"Kim","year":"2007","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0645","doi-asserted-by":"crossref","first-page":"d9","DOI":"10.2741\/927","article-title":"Molecular mechanisms of irradiation-induced apoptosis","volume":"8","author":"Zhou","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0650","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2741\/1903","article-title":"APO2 ligand\/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy","volume":"11","author":"Bucur","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0655","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1038\/sj.onc.1208888","article-title":"A small molecule Smac-mimic compound induces apoptosis and sensitizes T","volume":"24","author":"Bockbrader","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0660","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2006-04-015149","article-title":"Targeting mitochondrial factor Smac\/DIABLO as therapy for multiple myeloma","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0665","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1098231","article-title":"A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death","volume":"305","author":"Li","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0670","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2007.08.029","article-title":"Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis","volume":"12","author":"Petersen","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0675","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2007.01.011","article-title":"A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells","volume":"105","author":"Petrucci","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0680","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","article-title":"IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis","volume":"131","author":"Varfolomeev","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0685","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","article-title":"IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis","volume":"131","author":"Vince","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0690","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/jm0499108","article-title":"Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein\/caspase-9 interaction site","volume":"47","author":"Sun","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0695","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1128\/MCB.24.16.7003-7014.2004","article-title":"Upstream regulatory role for XIAP in receptor-mediated apoptosis","volume":"24","author":"Wilkinson","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0700","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/j.1460-2075.1996.tb00418.x","article-title":"Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant","volume":"15","author":"Rowan","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0705","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1073\/pnas.88.23.10657","article-title":"Mutations in p53 as potential molecular markers for human breast cancer","volume":"88","author":"Runnebaum","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0710","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/MCB.16.9.4952","article-title":"Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function","volume":"16","author":"Ludwig","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0715","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.2910600622","article-title":"Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis","volume":"60","author":"Bargou","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0720","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/09553000902838566","article-title":"Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling","volume":"85","author":"Efimova","year":"2009","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0725","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijrobp.2008.08.043","article-title":"Radiosensitization by inhibiting STAT1 in renal cell carcinoma","volume":"73","author":"Hui","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0730","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.0308102100","article-title":"STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells","volume":"101","author":"Khodarev","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0735","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-04-1883","article-title":"Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients","volume":"64","author":"Amundson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0740","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1158\/0008-5472.CAN-07-1019","article-title":"Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells","volume":"67","author":"Khodarev","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0745","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1242\/jcs.01728","article-title":"STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage","volume":"118","author":"Townsend","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0750","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0755","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/sj.onc.1204565","article-title":"Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase","volume":"20","author":"Macaulay","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0760","first-page":"6432","article-title":"Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer","volume":"63","author":"Min","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2017.02.003_bb0765","first-page":"65","article-title":"Endoplasmic reticulum stress response in cancer: molecular mechansim and therapeutic potential","volume":"2","author":"Wang","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0770","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10495-005-3088-0","article-title":"Role of the unfolded protein response in cell death","volume":"11","author":"Kim","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0775","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3748\/wjg.v9.i12.2635","article-title":"Reg gene family and human diseases","volume":"9","author":"Zhang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0780","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MPA.0b013e3181ac5337","article-title":"Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer","volume":"38","author":"Eguchi","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0785","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/auto.6.3.11625","article-title":"Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer","volume":"6","author":"Dalby","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0790","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0795","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0800","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/geno.1999.5851","article-title":"Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21","volume":"59","author":"Aita","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0805","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/07357900701206323","article-title":"Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma","volume":"25","author":"Daniel","year":"2007","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0810","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0815","first-page":"1453","article-title":"Beclin 1 gene inhibits tumor growth in colon cancer cell lines","volume":"27","author":"Koneri","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0820","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0825","first-page":"429","article-title":"Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours","volume":"30","author":"Miracco","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0830","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene","volume":"112","author":"Qu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0835","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4161\/auto.6827","article-title":"Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer","volume":"4","author":"Shen","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0840","first-page":"860","article-title":"Expression and clinical significance of autophagy gene Beclin 1 in cervical squamous cell carcinoma","volume":"37","author":"Wang","year":"2006","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0845","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/1541-7786.MCR-06-0229","article-title":"Tissue transglutaminase inhibits autophagy in pancreatic cancer cells","volume":"5","author":"Akar","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0850","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1158\/0008-5472.CAN-06-2387","article-title":"Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis","volume":"66","author":"Verma","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0855","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1349-7006.2008.00970.x","article-title":"Insulin-like growth factor stimulation increases radiosensitivity of a pancreatic cancer cell line through endoplasmic reticulum stress under hypoxic conditions","volume":"99","author":"Isohashi","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0860","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI40027","article-title":"The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5","volume":"120","author":"Rouschop","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0865","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/cbin.10463","article-title":"Signaling pathways and mechanisms of hypoxia-induced autophagy in the animal cells","volume":"39","author":"Fang","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0870","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/cr.2011.152","article-title":"Autophagy: for better or for worse","volume":"22","author":"Wirawan","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0875","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/cdd.2009.115","article-title":"Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells","volume":"17","author":"Romano","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0880","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/auto.7.8.15762","article-title":"A critical role for autophagy in pancreatic cancer","volume":"7","author":"Yang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0885","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0890","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/gcc.20337","article-title":"Pancreatic adenocarcinoma \u2014 genetic portrait from chromosomes to microarrays","volume":"45","author":"Karhu","year":"2006","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0895","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2009.89","article-title":"Pancreatic cancer: molecular pathogenesis and new therapeutic targets","volume":"6","author":"Wong","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0900","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1158\/0008-5472.CAN-05-0158","article-title":"Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras","volume":"65","author":"Brunner","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0905","first-page":"1210","article-title":"Core signaling pathways and new therapeutic targets in pancreatic cancer","volume":"123","author":"You","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0910","first-page":"2225","article-title":"ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block","volume":"13","author":"Nishii","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0915","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/382272a0","article-title":"Role for c-Abl tyrosine kinase in growth arrest response to DNA damage","volume":"382","author":"Yuan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0920","first-page":"1649","article-title":"Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline","volume":"55","author":"Fan","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0925","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jnci\/88.14.956","article-title":"UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53","volume":"88","author":"Wang","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0930","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/erc.0.0100001","article-title":"Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment","volume":"10","author":"Normanno","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0940","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.bjc.6602184","article-title":"Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma","volume":"91","author":"Abd El-Rehim","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0945","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0046-8177(90)90227-V","article-title":"Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma","volume":"21","author":"Kamio","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0950","doi-asserted-by":"crossref","first-page":"15873","DOI":"10.1021\/bi048604t","article-title":"A 120kDa nuclear phospholipase C gamma1 protein fragment is stimulated in vivo by EGF signal phosphorylating nuclear membrane EGFR","volume":"43","author":"Klein","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0955","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ncb0901-802","article-title":"Nuclear localization of EGF receptor and its potential new role as a transcription factor","volume":"3","author":"Lin","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0960","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/jcb.20876","article-title":"Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1","volume":"98","author":"Lo","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0965","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-005-9011-0","article-title":"EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization","volume":"95","author":"Lo","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0970","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.bjc.6602941","article-title":"Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival","volume":"94","author":"Lo","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0975","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840130104","article-title":"Localization of epidermal growth factor receptor in hepatocyte nuclei","volume":"13","author":"Marti","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0980","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/105072501300042785","article-title":"Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues","volume":"11","author":"Marti","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.bbcan.2017.02.003_bb0985","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/mcbr.2000.0177","article-title":"The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR","volume":"3","author":"Marti","year":"2000","journal-title":"Mol. Cell Biol. Res. Commun."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0990","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-05-0420","article-title":"Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis","volume":"11","author":"Psyrri","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb0995","doi-asserted-by":"crossref","first-page":"31182","DOI":"10.1074\/jbc.M506591200","article-title":"Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase","volume":"280","author":"Dittmann","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1000","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.06.022","article-title":"Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity","volume":"76","author":"Dittmann","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1005","doi-asserted-by":"crossref","first-page":"22136","DOI":"10.1074\/jbc.M301579200","article-title":"Novel localization of the DNA-PK complex in lipid rafts: a putative role in the signal transduction pathway of the ionizing radiation response","volume":"278","author":"Lucero","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1010","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1038\/sj.onc.1205500","article-title":"Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells","volume":"21","author":"Contessa","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1015","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1091\/mbc.10.8.2493","volume":"10","author":"Dent","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1667\/0033-7587(2003)159[0283:SARIAO]2.0.CO;2","article-title":"Stress and radiation-induced activation of multiple intracellular signaling pathways","volume":"159","author":"Dent","year":"2003","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.onc.1201275","article-title":"Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation","volume":"15","author":"Schmidt-Ullrich","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2005.06.024","article-title":"Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway","volume":"76","author":"Toulany","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1040","first-page":"915","article-title":"Phosphatidylinositide 3-kinase\/AKT in radiation responses","volume":"19","author":"Zhan","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1045","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1158\/0008-5472.CAN-06-2627","article-title":"Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation","volume":"66","author":"Das","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1050","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1158\/0008-5472.CAN-07-0242","article-title":"Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma","volume":"67","author":"Das","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0019-509X.82872","article-title":"Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?","volume":"48","author":"Agarwal","year":"2011","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1070","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2165\/11205010-000000000-00000","article-title":"Cetuximab: a review of its use in squamous cell carcinoma of the head and neck","volume":"70","author":"Frampton","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.795.11.2","article-title":"The effects of cetuximab alone and in combination with radiation and\/or chemotherapy in lung cancer","volume":"11","author":"Raben","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1080","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1200\/JCO.2010.31.7875","article-title":"Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA\/B non-small-cell lung cancer: RTOG 0324","volume":"29","author":"Blumenschein","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/030089161009600513","article-title":"Combination effect of cetuximab with radiation in colorectal cancer cells","volume":"96","author":"Shin","year":"2010","journal-title":"Tumori"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00423-010-0622-5","article-title":"Molecular mechanism of pancreatic cancer\u2014understanding proliferation, invasion, and metastasis","volume":"395","author":"Mihaljevic","year":"2010","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1095","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1158\/1078-0432.CCR-05-2860","article-title":"In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone)","volume":"12","author":"Barker","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1105","first-page":"23","article-title":"In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas","volume":"7","author":"Matsuoka","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1269\/jrr.43.43","article-title":"A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia","volume":"43","author":"Mizumoto","year":"2002","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0167-8140(00)00181-X","article-title":"Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole","volume":"56","author":"Shibamoto","year":"2000","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1269\/jrr.46.363","article-title":"Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo","volume":"46","author":"Yahiro","year":"2005","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.radonc.2008.02.007","article-title":"Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: long-term results of a placebo-controlled randomised study","volume":"87","author":"Karasawa","year":"2008","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00006676-200404000-00023","article-title":"Phase III trial of radiosensitizer PR-350 combined with intraoperative radiotherapy for the treatment of locally advanced pancreatic cancer","volume":"28","author":"Sunamura","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semradonc.2016.06.001","article-title":"Translation of targeted radiation sensitizers into clinical trials","volume":"26","author":"Reichert","year":"2016","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1140","first-page":"231","article-title":"Combining epidermal growth factor receptor inhibitors and radiation therapy in pancreatic cancer: small step or giant leap?","volume":"10","author":"Chang","year":"2009","journal-title":"JOP"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1145","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-09-1324","article-title":"Radiosensitization of epidermal growth factor receptor\/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status","volume":"16","author":"Kimple","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1150","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1158\/1078-0432.CCR-07-4072","article-title":"The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer","volume":"14","author":"Morgan","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1155","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1200\/jco.2008.26.15_suppl.4613","article-title":"Final results of a phase II trial [PARC-study ISRCTN56652283] for patients with primary inoperable locally advanced pancreatic cancer combining intensity-modulated radiotherapy (IMRT) with cetuximab and gemcitabine","volume":"26","author":"Munter","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdm441","article-title":"A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma","volume":"19","author":"Duffy","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1165","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2006.07.008","article-title":"Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer","volume":"66","author":"Maurel","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1170","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1200\/jco.2008.26.15_suppl.4629","article-title":"Cetuximab plus chemoradiation combined therapy for locally advanced inoperable pancreatic adenocarcinoma: a phase I study","volume":"26","author":"Demols","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2017.02.003_bb1175","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.ijrobp.2010.08.050","article-title":"Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer","volume":"82","author":"Robertson","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1200\/JCO.2005.04.1749","article-title":"Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results","volume":"24","author":"Czito","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1185","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40259-015-0130-9","article-title":"Next-generation covalent irreversible kinase inhibitors in NSCLC: focus on afatinib","volume":"29","author":"Hirsh","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/13543784.2014.924505","article-title":"Afatinib in the treatment of breast cancer","volume":"23","author":"Hurvitz","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00210-014-0967-3","article-title":"A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer","volume":"387","author":"Modjtahedi","year":"2014","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1205","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","article-title":"Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations","volume":"31","author":"Sequist","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2017.02.003_bb1210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11523-015-0403-8","article-title":"Afatinib, an irreversible EGFR family inhibitor, shows activity toward pancreatic cancer cells, alone and in combination with radiotherapy, independent of KRAS status","volume":"11","author":"Huguet","year":"2016","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1593\/neo.07124","article-title":"The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response","volume":"9","author":"Gupta","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1220","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-05-1220","article-title":"HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo","volume":"65","author":"Gupta","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1225","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2007.15.2355","article-title":"Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer","volume":"26","author":"Brunner","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4614-0254-1_14","article-title":"Histone deacetylase inhibitor: antineoplastic agent and radiation modulator","volume":"720","author":"Konsoula","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1235","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/MPA.0b013e3181dd63e1","article-title":"Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells","volume":"39","author":"Deorukhkar","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2016.04.013","article-title":"Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer","volume":"119","author":"Chan","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/OTT.S33560","article-title":"Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer","volume":"5","author":"Rich","year":"2012","journal-title":"Oncol. Targets Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1250","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.onc.1201296","article-title":"Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines","volume":"15","author":"Lerner","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1255","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1074\/jbc.272.22.14093","article-title":"Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo","volume":"272","author":"Rowell","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1260","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","article-title":"K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors","volume":"272","author":"Whyte","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1265","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1158\/1078-0432.CCR-04-0248","article-title":"A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer","volume":"10","author":"Martin","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2005.06.016","article-title":"Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity","volume":"8","author":"Moeller","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ijc.22294","article-title":"The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells","volume":"120","author":"Sasabe","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1280","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1535-7163.MCT-09-0768","article-title":"Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer","volume":"9","author":"Schwartz","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1158\/1535-7163.MCT-08-0981","article-title":"The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects","volume":"8","author":"Schwartz","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1290","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1535-7163.MCT-12-0098","article-title":"Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer","volume":"11","author":"Williams","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1295","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1158\/0008-5472.CAN-09-3573","article-title":"Mechanism of radiosensitization by the Chk1\/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair","volume":"70","author":"Morgan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1300","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/1078-0432.CCR-12-3748","article-title":"Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776","volume":"19","author":"Engelke","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1305","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.4161\/cc.10.24.18661","article-title":"Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1","volume":"10","author":"Vance","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bmb\/ldp005","article-title":"The potential role and application of PARP inhibitors in cancer treatment","volume":"89","author":"Chalmers","year":"2009","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1315","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1349-7006.2012.02268.x","article-title":"Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation","volume":"103","author":"Hirai","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1320","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1158\/1078-0432.CCR-14-1038","article-title":"Combined inhibition of Wee1 and PARP1\/2 for radiosensitization in pancreatic cancer","volume":"20","author":"Karnak","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1325","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1080\/15384101.2015.1104437","article-title":"MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways","volume":"14","author":"Estrada-Bernal","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1330","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1158\/1078-0432.CCR-13-0788","article-title":"Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C\/CDK1 and homologous recombination repair","volume":"19","author":"Wei","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1335","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1340","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4161\/cbt.21093","article-title":"The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy","volume":"13","author":"Prevo","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1350","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1074\/jbc.M110.188425","article-title":"RBX1 (RING box protein 1) E3 ubiquitin ligase is required for genomic integrity by modulating DNA replication licensing proteins","volume":"286","author":"Jia","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1355","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/0008-5472.CAN-11-2866","article-title":"Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor","volume":"72","author":"Wei","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1360","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1101\/gad.1863810","article-title":"Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase","volume":"24","author":"Niida","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1365","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-006-0227-4","article-title":"Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells","volume":"58","author":"Shafaee","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1370","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1375","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1158\/1078-0432.CCR-08-0291","article-title":"Sonic hedgehog promotes desmoplasia in pancreatic cancer","volume":"14","author":"Bailey","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1380","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1535-7163.MCT-12-1030","article-title":"Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis","volume":"12","author":"Gu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1385","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.surg.2006.03.014","article-title":"Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer","volume":"140","author":"Masui","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1395","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.surg.2009.10.033","article-title":"Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo","volume":"147","author":"Guoan","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1400","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1158\/0008-5472.CAN-05-1304","article-title":"ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition","volume":"65","author":"Dote","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1405","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-06-2181","article-title":"Inhibition of hsp90 compromises the DNA damage response to radiation","volume":"66","author":"Dote","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-717X-8-42","article-title":"Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990","volume":"8","author":"Milanovic","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1415","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1038\/sj.onc.1210498","article-title":"Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1","volume":"26","author":"Cordes","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1420","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2009.07.004","article-title":"Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells","volume":"92","author":"Hehlgans","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1425","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1593\/neo.92112","article-title":"GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer","volume":"12","author":"Watson","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1430","first-page":"568","article-title":"Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation therapy","volume":"1","author":"Sahu","year":"2009","journal-title":"Front Biosci. (Elite Ed.)"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1435","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/MPA.0b013e31821f677d","article-title":"Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death\/radiosensitization in pancreatic cancer cells","volume":"40","author":"Veeraraghavan","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1440","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fonc.2011.00019","article-title":"Guggulsterone-mediated enhancement of radiosensitivity in human tumor cell lines","volume":"1","author":"Choudhuri","year":"2011","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1445","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1016\/j.bmcl.2010.08.081","article-title":"Radiosensitization of cancer cells by hydroxychalcones","volume":"20","author":"Pruitt","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1450","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2009.06.021","article-title":"Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro","volume":"75","author":"Chung","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1022435202066","article-title":"L-canavanine as a radiosensitization agent for human pancreatic cancer cells","volume":"244","author":"Bence","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1460","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1465","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1470","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1073\/pnas.1219555110","article-title":"Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma","volume":"110","author":"Guillaumond","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1475","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: upstream and downstream of cancer metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1480","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2014.02.031","article-title":"Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy","volume":"89","author":"Dholakia","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1485","doi-asserted-by":"crossref","first-page":"17269","DOI":"10.1074\/jbc.272.28.17269","article-title":"Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades","volume":"272","author":"Deprez","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1490","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.freeradbiomed.2007.08.032","article-title":"2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer","volume":"44","author":"Coleman","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1495","first-page":"159","article-title":"Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle","volume":"17","author":"Galuska","year":"1991","journal-title":"Diabete Metab."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1500","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1667\/RR13568.1","article-title":"Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway","volume":"182","author":"Fasih","year":"2014","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1505","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2014.07.015","article-title":"AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells","volume":"112","author":"Shimura","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1510","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/0008-5472.CAN-14-1707","article-title":"Pharmacological ascorbate radiosensitizes pancreatic cancer","volume":"75","author":"Du","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1520","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1016627108","article-title":"Pyruvate carboxylase is required for glutamine-independent growth of tumor cells","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exphem.2013.12.001","article-title":"Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations","volume":"42","author":"Emadi","year":"2014","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1530","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1038\/cddis.2014.202","article-title":"Beta-lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1535","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/excr.2001.5234","article-title":"Beta-lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1\/xip3","volume":"267","author":"Planchon","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1540","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-015-0137-1","article-title":"Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ss-lapachone","volume":"3","author":"Chakrabarti","year":"2015","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1545","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3857\/roj.2013.31.2.57","article-title":"Enhancement of radiation effect using beta-lapachone and underlying mechanism","volume":"31","author":"Ahn","year":"2013","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1550","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-15-0765","article-title":"NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer","volume":"15","author":"Li","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1555","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjc.2014.385","article-title":"Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation","volume":"111","author":"Souchek","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000178871","article-title":"Genome-wide analysis of pancreatic cancer using microarray-based techniques","volume":"9","author":"Harada","year":"2009","journal-title":"Pancreatology"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1565","first-page":"89","article-title":"Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers","volume":"2","author":"Yang","year":"2011","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1570","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1575","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1580","doi-asserted-by":"crossref","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors","volume":"112","author":"Daemen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1585","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1590","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/jco.2006.24.18_suppl.4007","article-title":"RTOG 9704 a phase III study of adjuvant pre and post chemoradiation 5-FU Vs. Gemcitabine for resected pancreatic adenocarcinoma","volume":"24","author":"Regine","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1595","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1600","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/COC.0000000000000278","article-title":"Neoadjuvant therapy for pancreatic cancer: systematic review of postoperative morbidity, mortality, and complications","volume":"39","author":"Verma","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1605","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2003.11.004","article-title":"Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer","volume":"58","author":"Koong","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1610","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2005.07.002","article-title":"Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer","volume":"63","author":"Koong","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1615","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1620","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","article-title":"Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer","volume":"72","author":"Schellenberg","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1625","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2010.05.006","article-title":"Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer","volume":"81","author":"Schellenberg","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1630","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cncr.24059","article-title":"Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas","volume":"115","author":"Chang","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1635","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11605-010-1323-7","article-title":"Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients","volume":"14","author":"Didolkar","year":"2010","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1640","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2016.12.030","article-title":"Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: secondary analysis of a prospective clinical trial. Radiotherapy and oncology","author":"Verma","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1645","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1259\/bjr\/16386034","article-title":"Radiation damage and radioprotectants: new concepts in the era of molecular medicine","volume":"85","author":"Koukourakis","year":"2012","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1650","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/carcin\/16.4.767","article-title":"Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action","volume":"16","author":"Grdina","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1655","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1660","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00001813-200203000-00001","article-title":"Amifostine in clinical oncology: current use and future applications","volume":"13","author":"Koukourakis","year":"2002","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1665","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1667\/RR0758.1","article-title":"Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha","volume":"167","author":"Murley","year":"2007","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1670","first-page":"107","article-title":"Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation","volume":"29","author":"Makinde","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1675","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2016.02.036","article-title":"MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300\/HIF-1\/CREB binding to the promoter region of the PAI-1 gene","volume":"94","author":"Tong","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1680","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijrobp.2006.09.053","article-title":"Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury","volume":"67","author":"Rabbani","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1685","unstructured":"Onconova Therapeutics, Inc. 2017, Available from: http:\/\/www.onconova.com\/product-pipeline\/recilisib.php, [Last accessed 23 january 2017]."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1690","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1667\/RR1367.1","article-title":"Radiation protection by a new chemical entity, ex-rad: efficacy and mechanisms","volume":"171","author":"Ghosh","year":"2009","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1695","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1700","doi-asserted-by":"crossref","first-page":"161","DOI":"10.6004\/jnccn.2013.0024","article-title":"Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers","volume":"11","author":"Yu","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1705","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations","volume":"68","author":"Serra","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1710","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4161\/cbt.8.14.8633","article-title":"Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer","volume":"8","author":"Chun","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1715","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02151249","article-title":"The interaction of free radicals in protein and melanin","volume":"20","author":"Dain","year":"1964","journal-title":"Experientia"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1720","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1725","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jps.2600621102","article-title":"Fundamentals of interaction of ionizing radiations with chemical, biochemical, and pharmaceutical systems","volume":"62","author":"Schulman","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1730","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1735","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2015.12.020","article-title":"Current progress in immunotherapy for pancreatic cancer","volume":"381","author":"Foley","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1740","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"issue":"28","key":"10.1016\/j.bbcan.2017.02.003_bb1745","doi-asserted-by":"crossref","first-page":"43039","DOI":"10.18632\/oncotarget.9915","article-title":"Combination of radiotherapy and vaccination overcome checkpoint blockade resistance","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1750","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/j.gastro.2016.02.070","article-title":"Radiation therapy induces macrophages to suppress T-cell responses against pancreatic tumors in mice","volume":"150","author":"Seifert","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1755","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","volume":"59","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1760","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1765","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1770","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1245\/s10434-011-1630-6","article-title":"Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. intergroup\/RTOG 9704 phase III trial","volume":"18","author":"Regine","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1775","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","article-title":"Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients","volume":"237","author":"Lim","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1780","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1245\/s10434-009-0743-7","article-title":"Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study","volume":"17","author":"Hsu","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1785","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199705000-00018","article-title":"Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience","volume":"225","author":"Yeo","year":"1997","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1790","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0360-3016(03)00448-6","article-title":"Chemotherapy for advanced pancreatic cancer","volume":"56","author":"Haller","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1795","first-page":"205","article-title":"Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08","volume":"2","author":"John","year":"1996","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1800","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/02841868809090334","article-title":"Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx","volume":"27","author":"Overgaard","year":"1988","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1805","series-title":"Textbook of Radiotherapy","first-page":"330","author":"Fletcher","year":"1980"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1810","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0360-3016(94)00354-N","article-title":"Dose-response relationship for radiation therapy of subclinical disease","volume":"31","author":"Withers","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1815","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000rads) radiation alone, moderate dose radiation (4000rads+5-fluorouracil), and high dose radiation+5-fluorouracil: the gastrointestinal tumor study group","volume":"48","author":"Moertel","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1820","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.1985.3.3.373","article-title":"Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil\u2014an Eastern Cooperative Oncology Group study","volume":"3","author":"Klaassen","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1825","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/80.10.751","volume":"80","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1830","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","article-title":"Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies","volume":"25","author":"Huguet","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1835","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","volume":"19","author":"Chauffert","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1840","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1845","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/sonc.2002.37372","article-title":"Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials","volume":"29","author":"Heinemann","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1850","first-page":"705","article-title":"Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation","volume":"28","author":"Ogawa","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1855","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-09-4099","article-title":"Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics","volume":"70","author":"Feng","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1860","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.bjc.6602187","article-title":"Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation","volume":"91","author":"Fukuda","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1865","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/00029330-200809020-00014","article-title":"Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro","volume":"121","author":"Xu","year":"2008","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1870","article-title":"Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1875","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/1471-2407-14-808","article-title":"RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization","volume":"14","author":"Young","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2017.02.003_bb1880","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3892\/ijo.2014.2287","article-title":"Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study","volume":"44","author":"Suetens","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1885","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jrr\/rru070","article-title":"Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation","volume":"56","author":"Suetens","year":"2015","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.bbcan.2017.02.003_bb1890","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-4598-12-81","article-title":"miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer","volume":"12","author":"Wei","year":"2013","journal-title":"Mol. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16301238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X16301238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T18:16:28Z","timestamp":1658686588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X16301238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":378,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0304419X16301238"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.02.003","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological determinants of radioresistance and their remediation in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}